Treatment of Tinea Corporis with Itraconazole and Fluconazole

Introduction to Treatment Options

The American Academy of Pediatrics recommends prescribing itraconazole 100 mg once daily for 15 days for tinea corporis, as supported by pharmacokinetics showing affinity for keratinized tissues and continued activity after discontinuation 1

Itraconazole has a higher incidence of erratic oral bioavailability and more drug-drug interactions compared to fluconazole, with enhanced toxicity risk with certain medications 2
Itraconazole has a higher incidence of erratic oral bioavailability and more drug-drug interactions compared to fluconazole, with enhanced toxicity risk with certain medications 3
Itraconazole has a higher incidence of drug interactions, particularly with warfarin, certain antihistamines, antipsychotics, anxiolytics, digoxin, and statins 4
Fluconazole is a weaker cytochrome P450 inhibitor than itraconazole, resulting in fewer drug interactions 5
The British Association of Dermatologists notes that fluconazole is better tolerated than itraconazole with more predictable pharmacokinetics 2

The British Association of Dermatologists suggests that patients with multiple drug interactions where itraconazole's P450 inhibition is problematic should be prescribed fluconazole 5
The European Society of Clinical Microbiology and Infectious Diseases recommends that patients requiring simplified once-weekly dosing for compliance reasons should be prescribed fluconazole 2
The American Academy of Pediatrics advises to screen for drug interactions before prescribing itraconazole, particularly with warfarin, statins, and cardiac medications 4
The American Academy of Pediatrics recommends confirming diagnosis with mycological examination (KOH or culture) before initiating systemic therapy 1